Should Drug Manufacturers - Specialty & Generic Stock Ironwood Pharmaceuticals, Inc. (IRWD) Be in Your Portfolio Wednesday?

Ironwood Pharmaceuticals, Inc. (IRWD) is near the top in its industry group according to InvestorsObserver. IRWD gets an overall rating of 54. That means it scores higher than 54 percent of stocks. Ironwood Pharmaceuticals, Inc. gets a 76 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 106 out of 148 industries.

IRWD has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on IRWD!

See Full IRWD Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 54 would rank higher than 54 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Ironwood Pharmaceuticals, Inc. Stock Today?

Ironwood Pharmaceuticals, Inc. (IRWD) stock is lower by -1.39% while the S&P 500 has risen 0.36% as of 9:53 AM on Wednesday, Nov 1. IRWD is lower by -$0.12 from the previous closing price of $8.97 on volume of 236,920 shares. Over the past year the S&P 500 has gained 9.15% while IRWD is lower by -20.63%. IRWD lost -$6.04 per share the over the last 12 months. Click Here to get the full Stock Report for Ironwood Pharmaceuticals, Inc. stock.